Alivus Life Sciences Ltd Board of Directors
Board of Directors at Alivus Life Sciences Ltd
Chairman (Non-Executive)
Independent Director
Independent Non Exe. Director
Company Sec. & Compli. Officer
Independent Director
Key Highlights
- Hiren K. Patel joins the board as Chairman & Non Executive Dir., in a new position in 2026. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
- Yasir Yusufali Rawjee continues to serve as the Managing Director & CEO in 2026, maintaining the same position as in the previous year.
- Vinod Naik continues to serve as the ED / WTD / Head - Technical & Operations in 2026, maintaining the same position as in the previous year.
- Kaushikbhai N. Patel joins the board as Independent Non Exe. Director, in a new position in 2026. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
- Manju Agarwal continues to serve as the Independent Non Exe. Director in 2026, maintaining the same position as in the previous year.
Alivus Life Sciences Ltd
NSE: ALIVUS
Share Price
Last Ten Days Market Price
| Date | |
|---|---|
| 09 Oct 2026 | 1326.6 |
| 08 Oct 2026 | 1337.75 |
| 07 Oct 2026 | 1370.3 |
| 06 Oct 2026 | 1383.4 |
| 05 Oct 2026 | 1371.9 |
| 01 Oct 2026 | 1372.4 |
| 30 Sep 2026 | 1379.1 |
| 29 Sep 2026 | 1359.9 |
| 28 Sep 2026 | 1344.8 |
| 25 Sep 2026 | 1365.2 |
Company Fundamentals for Alivus Life Sciences Ltd
Market Cap
16,795 Cr
EPS
50.6
P/E Ratio (TTM)
26.2
P/B Ratio (TTM)
4.9
Day’s High
1375.0
Day’s Low
1354.95
DTE
0.0
ROE
16.9
52 Week High
1495.3
52 Week Low
830.0
ROCE
22.3
Market Price of Alivus Life Sciences Ltd
1M
1Y
3Y
5Y
Alivus Life Sciences Ltd News Hub
Glenmark Life Sciences Ltd leads gainers in 'A' group
Tamilnad Mercantile Bank Ltd, Marico Ltd, Rossari Biotech Ltd and Nestle India Ltd are among the oth
Read more
05 Aug 24
Glenmark Life Sciences AGM scheduled
Glenmark Life Sciences announced that the Annual General Meeting (AGM) of the company will be held o
Read more
06 Sept 24
Glenmark Life drops after PAT slides 20% YoY to Rs 95 crore in Q2
Profit before tax (PBT) dropped 19.8% YoY to Rs 127.46 crore in the quarter ended 30 September 2024.
Read more
25 Oct 24
Glenmark Life Sciences standalone net profit declines 19.72% in the September 2024 quarter
Net profit of Glenmark Life Sciences declined 19.72% to Rs 95.32 crore in the quarter ended Septembe
Read more
25 Oct 24
